Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Investment Securities (2016 - 2025)

Chemours has reported Gains from Investment Securities over the past 12 years, most recently at -$3.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$3.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$5.0 million (down 25.0% YoY), and the annual figure for FY2025 was $763000.0, up 77.44%.
  • Gains from Investment Securities for Q4 2025 was -$3.0 million at Chemours, down from $969000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CC hit a ceiling of $5.0 million in Q2 2023 and a floor of -$30.0 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $443000.0 (2023), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 3100.0% in 2022 and later skyrocketed 1540.59% in 2025.
  • Chemours' Gains from Investment Securities stood at $1.0 million in 2021, then plummeted by 3100.0% to -$30.0 million in 2022, then surged by 76.67% to -$7.0 million in 2023, then surged by 71.43% to -$2.0 million in 2024, then crashed by 50.0% to -$3.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$3.0 million (Q4 2025), $969000.0 (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.